Cardiovascular Systems (CSII) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Needham & Company Cuts Price Target on Cardiovascular Systems (CSII) to $37 Following 4Q15 Results
August 6, 2015 7:41 AM EDTNeedham & Company maintained a Strong Buy on Cardiovascular Systems (NASDAQ: CSII), and cut the price target to $37.00 (from $45.00), following 4Q15 results. Revenue was $48.5M (up 22.5% Y/Y) vs. consensus of $50.1M. EPS was ($0.27) vs. consensus of ($0.30). For F1Q16, CSII expects revenue of $48.5-50.0M vs.... More
